Additional file 11 of Therapeutical interference with the epigenetic landscape of germ cell tumors: a comparative drug study and new mechanistical insights

Additional file 11: Table S1. A Raw data of mass spectrometry analysis of histone modifications given as peptide frequency (n = 3). B Corresponding bar charts to (A) scaled to histone peptide frequency of 100%, 10% and 1%. C–I RNA seq data given as fold change compared to solvent control (log2) as well as DAVID functional annotation analysis for C Quisinostat, D JIB-04, E Chaetocin, F MZ-1, G LP99, H PRT4165 and I GSK343.